ResMed reported $273.71M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Ansell ANN:AU USD 206.2M 26.4M
Cochlear COH:AU AUD 629.3M 76.2M
Fisher & Paykel Healthcare FPH:AU NZD 69.8M 20.1M
Nanosonics Ltd NAN:AU AUD 2.09M 1.85M
Opthea Ltd OPT:AU USD 32.78M 79.66M
Regis Healthcare REG:AU AUD 4.15M 39.8M
ResMed RMD:AU USD 273.71M 71.94M